• Home
  • Dr Sonia Siddiqui

Dr Sonia Siddiqui

Name

Dr Sonia Siddiqui

Designation

Associate Professor Department of Biochemistry / Vice Principal SPGS / Deputy Chief Mentor

Email

sonia.siddiqui@duhs.edu.pk

Office

Room 62, Dept of Biochemistry, DIMC building, Ojha Campus, DUHS

Qualifications

  • M.Phil.
  • Ph.D. (Germany)
  • CHPE

Research

Neuroglia Interactions, Cell morphology and molecular neurobiology, Neurochemistry, Public health.

  • ResearchGate/ORCID link: 0000-0002-8883-5242
  • List of Selected Research Publications (with DOI citation): 
    1. Sonia Siddiqui, Andrea-Horvat Bröecker and Andreas Faissner. (2009). Comparative Screening of Glial Cell Types Reveals Extracellular Matrix that Inhibits Retinal Axon Growth in a Chondroitinase ABC-resistant Fashion. Glia. 2009 Oct; 57(13):1420-38. doi: 10.1002/glia.20860
    2. Sonia Siddiqui, Aisha Kamal, Faisal Khan, Khawar Saeed Jamali, Zafar Saeed Saify. (2018). Gallic and vanillic acid suppress inflammation and promote myelination in an in vitro mouse model of neurodegeneration. Molecular Biology Reports. https://doi.org/10.1007/s11033-018-4557-1 
    3. Sonia Siddiqui, Faisal Khan, Khawar Saeed Jamali, Syed Ghulam Musharraf. (2020). Madecassic acid reduces fast transient potassium channels and promotes neurite elongation in hippocampal CA1 neurons. CNS Neurol Disord Drug Targets. 2020;19(1):12-26. doi: 10.2174/1871527318666191111105508. 
    4. Nazia Feroz, Fauzia Imtiaz, Sonia Siddiqui, Lubna Ali. The relationship of maternal age, BMI, serum Tenascin-C, and HOMA-IR values with gestational diabetes mellitus. J Pak Med Assoc. 2024 Feb;74(1 (Supple-2)): S25-S28. doi: 10.47391/JPMA-DUHS-S06. 
  • Previous/Current Research Funding (Including VCSFI funding): 4
  • Title of the Grant:
    • 1-HEC project No:314/2023-2024 titled: “Anatomical changes ameliorated by the functionalized nanoparticles loaded with Medecassic acid and Epothilone D in an animal model of Parkinson’s disease”. Ongoing project. 2-HEC project No: 346/2022-23 titled: “Correlation of Serum Tenascin-C and Fetuin-A with Gestational Diabetes Mellitus in Pakistan”. Ongoing project 3- HEC project No: 2680 titled “Tenascin-C: A Novel therapeutic target for inflammation gated demyelination”. This project was completed in the year 2019. 4- HEC project No: 1026 titled “DNA Receptors and Schizophrenic Patients from Pakistan”. This project was completed in the year 2013.
  • Funding Agency:  Higher Education Commission of Pakistan (HEC)
  • Start and End Date (Years only): (1) 2009-2013, (2) 2010-2019, (3) 2023-2025, (4) 2024-2026
  • Total Funding in PKR: (1) 50 lacs (2) 50 lacs, (3) 19 lacs, (4) 25 lacs